Climacteron

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Climacteron
Combination of
Estradiol benzoate Estrogen
Estradiol dienanthate Estrogen
Testosterone enanthate benzilic acid hydrazone Androgen/anabolic steroid
Clinical data
Trade names Climacteron
Routes of
administration
Intramuscular injection
Identifiers
CAS Number
PubChem CID

Climacteron is a combination formulation of 1.0 mg estradiol benzoate, 7.5 mg estradiol dienanthate, and 150 mg testosterone enanthate benzilic acid hydrazone (69 mg testosterone base) which is used in the treatment of menopausal symptoms in postmenopausal women.[1][2] It is administered by intramuscular injection and is given once every 4 to 8 weeks or less frequently.[1]

See also[edit]

References[edit]

  1. ^ a b https://www.drugs.com/mmx/climacteron.html
  2. ^ Sherwin BB (1988). "Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women". Psychoneuroendocrinology. 13 (4): 345–57. doi:10.1016/0306-4530(88)90060-1. PMID 3067252.